News
Print Article

"193% Gain, 400 Days Late: Thanedar’s Trade Fuels STOCK Act Reform Debate"

13/08/2025

Representative Shri Thanedar disclosed a purchase of MicroStrategy (MSTR) stock valued between $15,001 and $50,000, made on July 1, 2024, but reported on August 11, 2025—over 400 days late, violating the STOCK Act’s 45-day reporting requirement.

The STOCK Act, signed into law in 2012, mandates the timely disclosure of congressional stock transactions to prevent insider trading. Thanedar’s fine for this violation is reported to be approximately $200, a standard penalty for late filings, though critics argue such fines are too lenient to deter non-compliance.

Since the purchase, MSTR’s stock price has risen significantly. On July 1, 2024, the stock was trading at approximately $135.99 (based on historical data adjusted for splits), and as of August 12, 2025, it’s at $396.58, reflecting a 193% increase, as you noted.

This gain aligns with MicroStrategy’s bitcoin-focused strategy, which has driven volatility and growth in its stock price.

Thanedar has faced scrutiny for other late disclosures, including 27 stock sales in 2024, five of which violated the STOCK Act, such as a Tesla sale of up to $100,000.

Since this story broke, many reports have suggested ongoing concerns about congressional trading transparency, with some calling for stricter enforcement or bans on stock trading by lawmakers.

MicroStrategy also faces a securities class action lawsuit for allegedly misleading investors about its bitcoin strategy’s profitability and risks, which may impact its stock.

Inside trading?

Based on the available information, Representative Shri Thanedar's late disclosure of his MicroStrategy (MSTR) stock purchase does violate the STOCK Act, but whether it constitutes insider trading or "inside dealing" is more nuanced.

 What Happened:

  • Purchase Date: July 1, 2024
  • Disclosure Date: August 11, 2025 — over 400 days late
  • STOCK Act Requirement: Disclosure within 45 days of the transaction
  • Penalty: A standard fine of approximately $200
  • Stock Performance: MSTR rose from ~$135.99 to ~$396.58 — a 193% gain.

 Legal vs. Ethical:

  • Legal Violation: Yes — Thanedar violated the STOCK Act by failing to disclose the trade within the required timeframe.
  • Insider Trading?: Not necessarily. The STOCK Act aims to prevent insider trading by requiring transparency, but late disclosure alone does not prove that Thanedar used non-public information for personal gain.

🧠 Context & Criticism:

  • The STOCK Act was designed to prevent lawmakers from profiting off privileged information.
  • Critics argue that the $200 fine is too lenient and does little to deter violations.
  • Thanedar’s case has drawn attention due to the significant profit from the trade and the lengthy delay in reporting

🔍 Is It Inside Dealing?

  • A violation of disclosure laws, not necessarily insider trading.
  • "Inside dealing" typically refers to trading based on material non-public information. Unless it's proven that Thanedar had such information when buying MSTR, this case is more accurately described as:

References

[1] Rep. Thanedar Faces STOCK Act Heat Over Late MicroStrategy Trade   https://deepnewz.com/us-legislation/rep-thanedar-faces-stock-act-heat-over-late-microstrategy-trade-acea2089

[2] A Congress Member Bought Up To $50K In Strategy Stock: Here ... - Benzinga https://www.benzinga.com/insights/government/25/08/47062946/a-congress-member-bought-up-to-50k-in-strategy-stock-heres-what-you-need-to-know

[3] Congress Trade: Representative Shri Thanedar Just Disclosed New Stock ...https://www.quiverquant.com/news/Congress+Trade%3A+Representative+Shri+Thanedar+Just+Disclosed+New+Stock+Trades

General

The Team

Meet the team of industry experts behind Comsure

Find out more

Latest News

Keep up to date with the very latest news from Comsure

Find out more

Gallery

View our latest imagery from our news and work

Find out more

Contact

Think we can help you and your business? Chat to us today

Get In Touch

News Disclaimer

As well as owning and publishing Comsure's copyrighted works, Comsure wishes to use the copyright-protected works of others. To do so, Comsure is applying for exemptions in the UK copyright law. There are certain very specific situations where Comsure is permitted to do so without seeking permission from the owner. These exemptions are in the copyright sections of the Copyright, Designs and Patents Act 1988 (as amended)[www.gov.UK/government/publications/copyright-acts-and-related-laws]. Many situations allow for Comsure to apply for exemptions. These include 1] Non-commercial research and private study, 2] Criticism, review and reporting of current events, 3] the copying of works in any medium as long as the use is to illustrate a point. 4] no posting is for commercial purposes [payment]. (for a full list of exemptions, please read here www.gov.uk/guidance/exceptions-to-copyright]. Concerning the exceptions, Comsure will acknowledge the work of the source author by providing a link to the source material. Comsure claims no ownership of non-Comsure content. The non-Comsure articles posted on the Comsure website are deemed important, relevant, and newsworthy to a Comsure audience (e.g. regulated financial services and professional firms [DNFSBs]). Comsure does not wish to take any credit for the publication, and the publication can be read in full in its original form if you click the articles link that always accompanies the news item. Also, Comsure does not seek any payment for highlighting these important articles. If you want any article removed, Comsure will automatically do so on a reasonable request if you email info@comsuregroup.com.